Suppression of 19S proteasome subunits marks emergence of an altered cell state in diverse cancers
Open Access
- 27 December 2016
- journal article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 114 (2) , 382-387
Abstract
Significance: In previous work, we used genome-wide screening to uncover a counterintuitive mechanism by which cells can acquire resistance to inhibitors of the proteasome’s catalytic core through experimentally induced imbalances in the composition of its regulatory particle. However, in many cases, mechanisms uncovered in vitro for acquired resistance often do not translate to the context of actual clinical cancers. Here, we show that this mechanism is actually deployed spontaneously and naturally in diverse human cancer lines and is associated not only with increased resistance to proteasome inhibitors both in vitro and in the clinic but also is symptomatic of a much more broadly altered state with a unique gene signature and drug targetable vulnerabilities.Keywords
This publication has 37 references indexed in Scilit:
- A Genome-wide siRNA Screen Identifies Proteasome Addiction as a Vulnerability of Basal-like Triple-Negative Breast Cancer CellsCancer Cell, 2013
- Sequence analysis of β-subunit genes of the 20S proteasome in patients with relapsed multiple myeloma treated with bortezomib or dexamethasoneBlood, 2012
- HSF1 Drives a Transcriptional Program Distinct from Heat Shock to Support Highly Malignant Human CancersCell, 2012
- Systematic identification of genomic markers of drug sensitivity in cancer cellsNature, 2012
- Molecular Mechanisms of Bortezomib Resistant Adenocarcinoma CellsPLOS ONE, 2011
- Transcription Factor Nrf1 Mediates the Proteasome Recovery Pathway after Proteasome Inhibition in Mammalian CellsMolecular Cell, 2010
- The basics of epithelial-mesenchymal transitionJournal of Clinical Investigation, 2009
- A Genome-wide RNAi Screen Identifies Multiple Synthetic Lethal Interactions with the Ras OncogeneCell, 2009
- Bortezomib-Resistant Nuclear Factor-κB Activity in Multiple Myeloma CellsMolecular Cancer Research, 2008
- The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem CellsCell, 2008